Skip to content

ACE applications are now open through October 15. Join a national network committed to providing high-quality, comprehensive Ataxia care. Apply Now!

Blog

L. Marins

I am Lucas Marins, Brazilian, 31 years old. My grandfather died with ataxia SCA3, my aunt is completely paralyzed already, my mother is 64 years old and has SCA3, suffering with no balance, severe difficult to Walk, insomnias, slight difficult in speaking and other symptoms. Myself, I was diagnosed with Read More…

Snapshot: What is Levacetylleucine?

Levacetylleucine, sold under the brand name Aqneursa, is an FDA-approved treatment for Niemann-Pick disease type C (NPC). It is an oral medicine, approved by the FDA in September 2024, later approved in the European Union in January 2026. Its exact mechanism of action remains unclear, but it is believed to Read More…

The impact of environmental factors on SCA6

Written by Tala Ortiz Edited by Celeste Suart, PhD   Ever wonder if experiences early in life impact symptoms of a genetic disease? Researchers found that genetics isn’t the only thing to consider in SCA6  Does the environment play a role in genetic diseases? That is the question these authors aim to answer in the context Read More…

Prajakta Samant and Amit Patil

Saga of a CHAIR Prajakta Samant and Amit Patil   When we hear a word “chair”, the first thing that comes to an Indian’s mind is electoral seat in politics. But don’t worry—I’m not going there today. To hell with politics. I’m here to talk about a very different kind of a chair.  My mother was a teacher. As students, we would sit on benches while she sat on a big, sturdy chair. I used to look Read More…

Marcus

My Mother was diagnosed with a type of ataxia 20 years ago, no one knew what exactly she had. 10 years ago, I started researching about my mothers illness as I knew that whatever she had, was genetically passed on. So I made some appointments but soon realised that nobody Read More…

Snapshot: What Is an Expanded Access Program?

When faced with a serious illness and no effective treatment, patients may look to experimental therapies as a last resort. Normally, patients can only access experimental drugs or other investigational medical products through clinical trials. Unfortunately, not everyone can access a clinical trial when they need it. Some live too far Read More…

Anamaria

A 29-Year Journey to the Truth My name is Anamaria Mitre, I am from Zalau, Romania, and I am 42 years old. If you saw me today, you would find me enjoying the quiet joys of life. I love reading, watching movies and TV series, solving crosswords, and playing Rummy. Although I don’t drive, Read More…

The Hike You’ll Never Forget

When Mark Minkin signed up for Xtreme Hike, he wasn’t just taking on a mountain. He was taking on a challenge that would honor his wife and help raise awareness for everyone living with Ataxia. Along the way, he discovered something even bigger. “The views were spectacular, the encouragement from Read More…

Introducing National Ataxia Foundation’s Enhanced Support Program

Enhancing Community Through Professional Support For decades, NAF Support Groups have provided a welcoming place for people living with Ataxia, caregivers, family members, and loved ones to connect with others who understand their journey. Led by dedicated volunteer Support Group Leaders, these groups offer encouragement, shared experiences, and meaningful community. Read More…

The influence of age on the severity of SCA2 

Written by Ross Pelzel    Edited by Dr. Larissa Nitschke  New mouse studies show that mutant ataxin-2 causes dramatically more damage in older animals, revealing aging as an independent driver of disease severity    In Afonso et al. 2022, the authors set out to understand how age influences the development of symptoms in spinocerebellar ataxia Read More…

Translate »

Join the Ataxia community today!

Become a free member for exclusive content from NAF.